Acadia Healthcare (ACHC) Set to Release Earnings on Wednesday

Acadia Healthcare (NASDAQ:ACHC) is anticipated to announce its Q3 2026 results after the market closes on Wednesday, November 4th. Analysts expect Acadia Healthcare to announce earnings of $0.4625 per share and revenue of $877.76 million for the quarter. Interested persons are encouraged to explore the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Thursday, November 5, 2026 at 9:00 AM ET.

Acadia Healthcare Price Performance

Acadia Healthcare stock opened at $29.96 on Monday. Acadia Healthcare has a 12-month low of $11.43 and a 12-month high of $35.83. The stock has a market capitalization of $2.79 billion, a P/E ratio of -2.41, a P/E/G ratio of 9.65 and a beta of 0.63. The firm’s 50-day moving average is $29.08 and its two-hundred day moving average is $25.64. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.57 and a quick ratio of 1.57.

Analysts Set New Price Targets

Several research analysts have weighed in on the company. Cantor Fitzgerald reiterated a “neutral” rating on shares of Acadia Healthcare in a report on Tuesday, October 6th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Acadia Healthcare in a research report on Wednesday, September 9th. Guggenheim upped their target price on Acadia Healthcare from $38.00 to $39.00 and gave the company a “buy” rating in a research note on Thursday, July 30th. Leerink Partners increased their target price on Acadia Healthcare from $30.00 to $33.00 and gave the stock a “market perform” rating in a research report on Wednesday, September 23rd. Finally, Raymond James Financial cut Acadia Healthcare from a “strong-buy” rating to an “outperform” rating and set a $39.00 price target for the company. in a report on Monday, September 28th. Eight investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $30.69.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services headquartered in Franklin, Tennessee. The company operates psychiatric hospitals, specialty treatment facilities and outpatient programs focused on mental health and substance use disorders.

Acadia’s services include inpatient and outpatient psychiatric care, addiction treatment, residential treatment, eating-disorder programs, and services for children and adolescents. Its facilities serve patients with a range of behavioral health conditions, including depression, anxiety, trauma-related disorders and substance use disorders.

Founded in 2005, Acadia operates primarily in the United States and also has a significant presence in the United Kingdom through its ownership of Priory, a behavioral healthcare provider.